Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Case-control
Cohort
Study drug and medical condition

Medical condition to be studied

Pneumonia

Additional medical condition(s)

COVID-19PneumoniaViral Infection
Population studied

Age groups

Term newborn infants (0 – 27 days)
Infants and toddlers (28 days – 23 months)
Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

8000
Study design details

Main study objective

Describing the characteristics of subjects screened and/or diagnosed with COVID-19 in Spain Describing therapeutic management in the clinical practice Describing clinical outcomes for the infected subjects Assessing predictor factors for infection, hospitalization,intensive care admission and death Exploring effectiveness and safety of administered therapies

Outcomes

Sociodemographic and lifestyle Geographical/Ethnic origin History of exposure to COVID-19 and dates, test results and viral load, if available Current and past concomitant medications Current and past comorbidities Diagnosis, clinical symptoms and signs Laboratory values Severity scores, Infection status Pneumonia status Recovery status and time to recovery Hospitalization and length of stay ICU admission and length of stay Overall survival Complications during infection (bacterial pneumonia, sepsis…) Recurrence/reinfection

Data analysis plan

Descriptive analysis in the overall sample and by subgroups of interest (e.g. Hospital, gender, age subgroups, smoking history, diabetes status, cardiovascular history etc.) Multivariable Cox Regression to estimate Hazard ratios Multivariable Logistic Regression to estimate Odds ratios
Documents